Published in Endocr Rev on November 10, 2009
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis (2011) 10.96
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS (2010) 2.23
Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms. Endocrinology (2013) 1.81
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med (2015) 1.61
Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent Pathway. PLoS Pathog (2016) 1.41
HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV (2015) 1.31
Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues. AIDS Res Hum Retroviruses (2012) 1.23
Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle. Mucosal Immunol (2013) 1.22
Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs. Contraception (2014) 1.15
Alcohol use, mycoplasma genitalium, and other STIs associated With HIV incidence among women at high risk in Kampala, Uganda. J Acquir Immune Defic Syndr (2013) 1.11
Research gaps in defining the biological link between HIV risk and hormonal contraception. Am J Reprod Immunol (2014) 1.08
Progesterone and autoimmune disease. Autoimmun Rev (2011) 1.05
Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases. Bioessays (2012) 1.04
Sex differences in HIV RNA level and CD4 cell percentage during childhood. Clin Infect Dis (2011) 0.99
A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge. Sci Transl Med (2015) 0.99
Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial. Hum Reprod (2014) 0.98
Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception. AIDS (2014) 0.96
Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis. PLoS One (2013) 0.94
Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior. Brain Struct Funct (2013) 0.92
Hormonal contraceptive use and risk of HIV-1 disease progression. AIDS (2013) 0.92
An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women. AIDS (2016) 0.88
Contraceptive methods and risk of HIV acquisition or female-to-male transmission. Curr HIV/AIDS Rep (2014) 0.88
Progesterone Levels Associate with a Novel Population of CCR5+CD38+ CD4 T Cells Resident in the Genital Mucosa with Lymphoid Trafficking Potential. J Immunol (2016) 0.86
Hormone replacement therapy and risk for neurodegenerative diseases. Int J Alzheimers Dis (2012) 0.86
An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques. Drug Deliv Transl Res (2017) 0.86
Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting. AIDS Behav (2015) 0.85
Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study. J Reprod Immunol (2013) 0.85
The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota. AIDS (2013) 0.85
Living with uncertainty: acting in the best interests of women. AIDS Res Treat (2012) 0.84
Distinct characteristics of endometrial and decidual macrophages and regulation of their permissivity to HIV-1 infection by SAMHD1. J Virol (2014) 0.83
Nanoparticle-based drug delivery to the vagina: a review. J Control Release (2014) 0.83
17β-estradiol protects primary macrophages against HIV infection through induction of interferon-alpha. Viral Immunol (2014) 0.82
Trends in contraceptive use among women with human immunodeficiency virus. Obstet Gynecol (2012) 0.82
Advances in HIV microbicide development. Future Med Chem (2011) 0.81
Effect of hormonal contraception on the function of plasmacytoid dendritic cells and distribution of immune cell populations in the female reproductive tract. J Acquir Immune Defic Syndr (2015) 0.79
Sex steroid hormones regulate constitutive expression of Cyp2e1 in female mouse liver. Am J Physiol Endocrinol Metab (2013) 0.79
Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent manner. J Biol Chem (2014) 0.78
Contraception in HIV-positive female adolescents. AIDS Res Ther (2011) 0.78
Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women. J Acquir Immune Defic Syndr (2015) 0.77
Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive. J Reprod Immunol (2015) 0.77
Molecular mechanisms linking high dose medroxyprogesterone with HIV-1 risk. PLoS One (2015) 0.76
Atherosclerosis is Evident in Treated HIV-Infected Subjects With Low Cardiovascular Risk by Carotid Cardiovascular Magnetic Resonance. J Acquir Immune Defic Syndr (2016) 0.76
Characterization of the Genital Microenvironment of Female Rhesus Macaques Prior to and After SIV Infection. Am J Reprod Immunol (2015) 0.76
Quotidian changes of genital tract cytokines in human immunodeficiency virus-1-infected women during the menstrual cycle. Open Forum Infect Dis (2014) 0.75
Recent Insights into the HIV/AIDS Pandemic. Microb Cell (2016) 0.75
Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data. J Acquir Immune Defic Syndr (2017) 0.75
Contraceptive challenges in adolescents living with or at risk of HIV. J Virus Erad (2016) 0.75
Fcgbp - A Potential Viral Trap in RV144. Open AIDS J (2014) 0.75
Virologic failure in an HIV-infected woman given desogestrel for excessive menstrual bleeding. Eur J Clin Pharmacol (2010) 0.75
Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med (2006) 24.38
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science (1996) 18.38
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature (2005) 13.15
Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science (1998) 12.81
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature (2005) 11.12
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med (2004) 9.11
Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science (2004) 8.68
Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol (2004) 8.45
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis (1991) 7.05
Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis (1999) 6.85
Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity (2007) 6.36
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med (2003) 5.71
Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS (1998) 5.64
Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med (1996) 5.63
Hormonal contraception and the risk of HIV acquisition. AIDS (2007) 5.05
Helping the CD8(+) T-cell response. Nat Rev Immunol (2004) 4.90
Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet (2005) 4.51
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (2008) 4.21
The complex role of estrogens in inflammation. Endocr Rev (2007) 4.07
Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol (2001) 4.03
HIV/AIDS in women: an expanding epidemic. Science (2005) 3.68
Setting the stage: host invasion by HIV. Nat Rev Immunol (2008) 3.25
Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet (1988) 3.21
Sex hormones and the immune response in humans. Hum Reprod Update (2005) 3.13
Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol (1995) 3.11
Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev (2005) 3.01
A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest (1994) 3.00
Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis (1998) 2.96
Mechanism and control of class-switch recombination. Trends Immunol (2002) 2.95
The regulation of IgA class switching. Nat Rev Immunol (2008) 2.92
Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet (1997) 2.88
The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS (1998) 2.80
Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin Infect Dis (2006) 2.65
NIH conference. Gastrointestinal infections in AIDS. Ann Intern Med (1992) 2.62
Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. J Natl Cancer Inst (2005) 2.60
Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst (2003) 2.58
Regulation of the immune system by sex steroids. Endocr Rev (1984) 2.55
Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women. J Infect Dis (2004) 2.47
Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J Infect Dis (1994) 2.41
Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA (1993) 2.41
Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J Exp Med (1999) 2.24
A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol (2007) 2.17
Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J Virol (2003) 2.04
Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med (1991) 2.04
Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol (2006) 2.04
Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis (2004) 2.03
Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses (1998) 1.99
Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol (1995) 1.99
Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol (2001) 1.95
Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr (1993) 1.91
Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J Immunol (2005) 1.83
Selective depletion of rectal lamina propria rather than lymphoid aggregate CD4 lymphocytes in HIV infection. Clin Exp Immunol (1997) 1.82
Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. Am J Reprod Immunol (2005) 1.80
Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol (2003) 1.79
Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol (1989) 1.76
Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J Med Primatol (1992) 1.70
CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol (1996) 1.70
Human immunodeficiency virus type 1 infection in women attending a sexually transmitted diseases clinic in Kenya. J Infect Dis (1992) 1.70
The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions. J Infect Dis (2002) 1.67
CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol (1997) 1.62
Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis (1993) 1.60
Granulated lymphocytes of pregnancy. Placenta (1996) 1.60
Risk factors associated with prevalent HIV-1 infection among pregnant women in Rwanda. National University of Rwanda-Johns Hopkins University AIDS Research Team. Int J Epidemiol (1994) 1.60
Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS (2003) 1.60
Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals. AIDS Res Hum Retroviruses (2004) 1.58
Incident HIV-1 infection in a cohort of young women in Butare, Rwanda. AIDS (1994) 1.54
Hormonal contraception and HIV prevalence in four African countries. Contraception (2008) 1.53
Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis (2000) 1.52
Compartmentalization of the mucosal immune responses to commensal intestinal bacteria. Ann N Y Acad Sci (2004) 1.52
Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin Exp Immunol (1996) 1.51
Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV). Ann Intern Med (1988) 1.51
The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception (1999) 1.50
Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol (2000) 1.50
The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones. Clin Exp Immunol (2002) 1.50
Getting to the guts of HIV pathogenesis. J Exp Med (2004) 1.47
Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J Virol (2003) 1.46
A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding. AIDS (2001) 1.45
Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells. J Immunol (2008) 1.44
Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am J Obstet Gynecol (2000) 1.44
Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut (1999) 1.42
Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis (1995) 1.40
The number and distribution of immune cells in the cervicovaginal mucosa remain constant throughout the menstrual cycle of rhesus macaques. Clin Immunol (2001) 1.37
Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. Am J Pathol (1993) 1.37
Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J Infect Dis (1989) 1.37
Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol (1983) 1.36
Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS (2004) 1.35
Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology (2006) 1.34
Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J Infect Dis (2004) 1.33
Intestinal IgA: novel views on its function in the defence of the largest mucosal surface. Gut (1999) 1.32
The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS (2004) 1.32
Cyclic shedding of HIV-1 RNA in cervical secretions during the menstrual cycle. J Infect Dis (2004) 1.31
Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J Exp Med (1981) 1.31
Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol (1997) 1.31
Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol (1999) 1.29
The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression. Reprod Sci (2009) 1.28
Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women. AIDS (2007) 1.28
Antiretroviral therapies in women after single-dose nevirapine exposure. N Engl J Med (2010) 3.14
Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat Med (2002) 3.04
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest (2009) 2.82
The pathophysiology of IgA nephropathy. J Am Soc Nephrol (2011) 2.27
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest (2008) 2.15
Antiretroviral therapy in antenatal care to increase treatment initiation in HIV-infected pregnant women: a stepped-wedge evaluation. AIDS (2010) 2.11
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int (2005) 2.08
Access to biologic therapies in Canada for children with juvenile idiopathic arthritis. J Rheumatol (2012) 1.97
Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int (2002) 1.88
Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol (2008) 1.76
IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol (2008) 1.64
Approaches for scaling up human immunodeficiency virus testing and counseling in prevention of mother-to-child human immunodeficiency virus transmission settings in resource-limited countries. Am J Obstet Gynecol (2007) 1.63
Mucosal immunoglobulins. Immunol Rev (2005) 1.60
Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins. Virology (2006) 1.51
Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry. J Biol Chem (2005) 1.50
Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. J Biol Chem (2010) 1.48
Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins. Mol Immunol (2007) 1.45
Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy. Anal Bioanal Chem (2007) 1.37
Health facility characteristics and their relationship to coverage of PMTCT of HIV services across four African countries: the PEARL study. PLoS One (2012) 1.35
Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J Infect Dis (2004) 1.33
Humoral immune responses to microbial infections in the genital tract. Microbes Infect (2002) 1.32
Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire. J Virol (2007) 1.26
Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference. Arthritis Care Res (Hoboken) (2012) 1.25
Enhancing oral vaccine potency by targeting intestinal M cells. PLoS Pathog (2010) 1.22
Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation. Mol Cell Proteomics (2010) 1.21
Detection of mucosal antibodies in HIV type 1-infected individuals. AIDS Res Hum Retroviruses (2002) 1.21
Acceptability of neonatal male circumcision in Lusaka, Zambia. AIDS Care (2011) 1.21
Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals. AIDS (2005) 1.18
IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. Contrib Nephrol (2007) 1.17
HIV infection: first battle decides the war. Trends Immunol (2006) 1.15
Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol (2007) 1.14
Human male genital tract secretions: both mucosal and systemic immune compartments contribute to the humoral immunity. J Immunol (2005) 1.11
IgA-containing immune complexes in the urine of IgA nephropathy patients. Nephrol Dial Transplant (2006) 1.09
Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol (2012) 1.09
The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells. PLoS Pathog (2013) 1.07
Naturally occurring structural isomers in serum IgA1 o-glycosylation. J Proteome Res (2011) 1.05
Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study. Biochemistry (2010) 1.02
Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells. J Mol Biol (2007) 1.02
Nevirapine for the prevention of mother-to-child transmission of HIV: a nation-wide coverage survey in Côte d'Ivoire. J Acquir Immune Defic Syndr (2011) 1.01
Acceptability and uptake of neonatal male circumcision in Lusaka, Zambia. AIDS Behav (2013) 1.01
Neutralizing antibodies in mucosal secretions: IgG or IgA? Curr HIV Res (2007) 1.00
IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells. Nephrol Dial Transplant (2011) 0.99
Expression of homing receptors on IgA1 and IgA2 plasmablasts in blood reflects differential distribution of IgA1 and IgA2 in various body fluids. Clin Vaccine Immunol (2010) 0.97
IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1. Contrib Nephrol (2007) 0.97
Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis. Rheumatology (Oxford) (2010) 0.97
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. J Infect Dis (2004) 0.97
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. J Infect Dis (2002) 0.96
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study. Antimicrob Agents Chemother (2011) 0.96
The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment. PLoS One (2012) 0.95
Immune responses to human papillomavirus in genital tract of women with cervical cancer. Gynecol Oncol (2005) 0.89
A systematic review of transition readiness and transfer satisfaction measures for adolescents with chronic illness. Int J Adolesc Med Health (2014) 0.89
Tolerance and protection against infection in the genital tract. Immunol Invest (2010) 0.89
Mucosal HIV vaccines: a holy grail or a dud? Vaccine (2010) 0.87
Intranasal immunization with influenza virus and Korean mistletoe lectin C (KML-C) induces heterosubtypic immunity in mice. Vaccine (2007) 0.86
Chronic inflammatory arthritis prevalence estimates for children and adolescents in three Canadian provinces. Rheumatol Int (2014) 0.85
Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responses. Vaccine (2008) 0.85
Hydrostatic pressure induces the fusion-active state of enveloped viruses. J Biol Chem (2001) 0.84
Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system. Adv Otorhinolaryngol (2011) 0.83
IgA nephropathy: a clinical overview. Contrib Nephrol (2007) 0.83
Comparative Evaluation of HIV-1 Neutralization in External Secretions and Sera of HIV-1-Infected Women. Open AIDS J (2012) 0.82
European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research. Vaccine (2005) 0.82
Menstrual blood as a potential source of endometrial derived CD3+ T cells. PLoS One (2011) 0.81
Systemic and mucosal differences in HIV burden, immune, and therapeutic responses. J Acquir Immune Defic Syndr (2011) 0.81
Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration. Ann N Y Acad Sci (2004) 0.81
The financial burden of juvenile idiopathic arthritis: a Nova Scotia experience. Pediatr Rheumatol Online J (2013) 0.79
Safety and outcomes of outpatient pediatric otolaryngology procedures at an ambulatory surgery center. Laryngoscope (2008) 0.79
In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells. Results Immunol (2012) 0.78
Cloning and expression of the turtle (Trachemys scripta) immunoglobulin joining (J)-chain cDNA. Immunogenetics (2002) 0.78
Mucosal antibody responses to HIV. Methods Mol Biol (2009) 0.78
Tissue distribution and biological activities of immune complexes are determined by their size and composition. Nephrol Dial Transplant (2009) 0.77
Clinical and research searching on the wild side: exploring the veterinary literature. J Med Libr Assoc (2009) 0.75
Clinical images: venolymphatic malformation in an adolescent girl. Arthritis Rheum (2010) 0.75
USE OF COMPOSITE MATERIALS AS A COMPONENT OF TUSK FRACTURE MANAGEMENT IN AN ASIAN ELEPHANT (ELEPHAS MAXIMUS) AND AN AFRICAN ELEPHANT (LOXODONTA AFRICANA). J Zoo Wildl Med (2017) 0.75
Origin of galactose-deficient immunoglobulin g in gingival crevicular fluid in periodontitis. J Periodontol (2014) 0.75
Influenza virus infection of the murine uterus: a new model for antiviral immunity in the female reproductive tract. Viral Immunol (2006) 0.75
Trajectories of pain severity in juvenile idiopathic arthritis: results from the Research in Arthritis in Canadian Children Emphasizing Outcomes cohort. Pain (2017) 0.75
Cloning of the chicken immunoglobulin joining (J)-chain gene and characterization of its promoter region. DNA Cell Biol (2002) 0.75
SINUSITIS, BRONCHIECTASIS, AND FLATUS IN A SUMATRAN ORANGUTAN (PONGO ABELII): COULD THIS BE CYSTIC FIBROSIS? J Zoo Wildl Med (2016) 0.75
Physical therapy as an adjunctive treatment for severe osteoarthritis in a Komodo dragon (Varanus komodoensis). J Zoo Wildl Med (2015) 0.75